1.Total alkaloids from Thesium chinense inhibit lipopolysaccharide-induced respiratory inflammation by modulating Nrf2/NF-κB/NLRP3 signaling pathway.
Guohui LI ; Yueqin GUAN ; Lintao XU ; Guangcheng PENG ; Qingtong HAN ; Tian WANG ; Zhenpeng XU ; Xuesen WEN ; Hongxiang LOU ; Tao SHEN
Chinese Journal of Natural Medicines (English Ed.) 2025;23(4):421-430
Inflammation plays a pivotal role in the etiology and progression of various diseases. In traditional Chinese medicine, the whole plants of Thesium chinense Turcz. and its preparations (e.g. Bairui Granules) have been employed to manage inflammatory conditions. While flavonoids were previously considered the primary anti-inflammatory components, other potentially active constituents have been largely overlooked and not thoroughly investigated. This study presents a novel finding that the total alkaloids of T. chinense (BC-Alk) are potent active substances underlying the traditional and clinical applications of T. chinense and Bairui Granules as anti-inflammatory agents. UPLC-MS/MS analysis identified the composition of BC-Alk as quinolizidine alkaloids. The anti-inflammatory efficacy of BC-Alk was evaluated using a lipopolysaccharide (LPS)-induced lung inflammation model in mice. Results demonstrated that BC-Alk significantly mitigated LPS-induced lung inflammation, attenuated the overproduction of IL-1β and the overproduction of inflammatory factors (TNF-α), and ameliorated lung tissue hyperplasia in mice in vivo. Mechanistic studies in vitro revealed that BC-Alk upregulated the expression of Nrf2 and its downstream proteins NQO1 and glutamate-cystine ligase and modifier subunit (GCLM), inhibited NF-κB phosphorylation, and suppressed NLRP3 activation. Collectively, these findings indicate that BC-Alk exerts potent inhibitory effects against lung inflammation by modulating Nrf2, NF-κB, and NLRP3 pathways. This study provides new insights into the anti-inflammatory constituents of T. chinense and Bairui Granules.
Animals
;
Lipopolysaccharides/adverse effects*
;
Alkaloids/pharmacology*
;
NF-kappa B/metabolism*
;
NF-E2-Related Factor 2/metabolism*
;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*
;
Mice
;
Signal Transduction/drug effects*
;
Anti-Inflammatory Agents/pharmacology*
;
Male
;
Mice, Inbred C57BL
;
Humans
;
Drugs, Chinese Herbal/administration & dosage*
;
Pneumonia/genetics*
2.Advances in endothelial glycocalyx in rheumatic and immune diseases
Qianjun CHEN ; Weijie LI ; Jing XIE ; Lintao WEN ; Ronghao ZHENG
International Journal of Pediatrics 2025;52(7):461-465
The endothelial glycocalyx(EG)is a villous polyglycoprotein complex that covers the apical membrane of endothelial cells,situated between the blood vessel wall and the bloodstream.Due to its unique physiological position,the EG plays a crucial role in vascular permeability,mechanical conduction,coagulation,inflammation,and other processes.EG injury can cause endothelial barrier dysfunction,increase vascular permeability,and promote inflammation and thrombosis.Recent studies have revealed that the involvement of EG in inflammatory responses may contribute significantly to the pathogenesis of certain rheumatic and immune diseases as well as multi-system inflammatory syndrome,Kawasaki disease,rheumatoid arthritis,systemic lupus erythematosus and antiphospholipid syndrome,etc.This review paper aims to provide an overview of the structure and function of EG while highlighting its research progress in diagnosing and treating rheumatic and immune diseases.

Result Analysis
Print
Save
E-mail